Telix Pharmaceuticals (TLPPF) Stock Forecast & Price Target

$13.08

+0.44 (+3.48%)

(As of 07/5/2024 ET)

Stock Analysis Analyst Forecasts Chart Headlines Short Interest

Telix Pharmaceuticals - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Strong Sell
Based on 1 Analyst Ratings

Consensus Price Target

N/A

Type	Current Forecast 7/7/23 to 7/6/24	1 Month Ago 6/7/23 to 6/6/24	3 Months Ago 4/8/23 to 4/7/24	1 Year Ago 7/7/22 to 7/7/23
Consensus Rating	Strong Sell	Strong Sell	Strong Sell	N/A
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	N/A
Buy	0 Buy rating(s)	0 Buy rating(s)	0 Buy rating(s)	N/A
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	N/A
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	N/A
Consensus Price Target	N/A	N/A	N/A	N/A
Forecasted Upside	N/A	N/A	N/A	N/A

Get Telix Pharmaceuticals Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for TLPPF and its competitors with MarketBeat's FREE daily newsletter.

Ad Weiss Ratings

Nvidia’s Quiet $1 Trillion Pivot

Nvidia recently added $277 billion in market cap … IN ONE DAY.

Find out details on these three critical Nvidia partners immediately.

TLPPF Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

TLPPF Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Telix Pharmaceuticals Stock vs. The Competition

Type	Telix Pharmaceuticals	Medical Companies	S&P 500
Consensus Rating Score	1.00	2.71	2.50
Consensus Rating	Strong Sell	Moderate Buy	Moderate Buy
Predicted Upside		995.78% Upside	12.26% Upside
News Sentiment Rating	Neutral News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date	Details
7/20/2023	CLSA Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Underperform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 12:48 PM ET.

TLPPF Forecast - Frequently Asked Questions

Should I buy or sell Telix Pharmaceuticals stock right now?: 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Telix Pharmaceuticals in the last twelve months. There is currently 1 sell rating for the stock. The consensus among Wall Street analysts is that investors should "sell" TLPPF shares.
Do Wall Street analysts like Telix Pharmaceuticals more than its competitors?: Analysts like Telix Pharmaceuticals less than other "medical" companies. The consensus rating for Telix Pharmaceuticals is Strong Sell while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how TLPPF compares to other companies.